Gupta Himanshu, Anvikar Anup R, Bharti Praveen K
Department of Biotechnology, Institute of Applied Sciences & Humanities, GLA University, Mathura, Uttar Pradesh, India.
ICMR-National Institute of Malaria Research (ICMR-NIMR), Dwarka, New Delhi, India.
Am J Trop Med Hyg. 2025 Apr 1;112(6):1193-1195. doi: 10.4269/ajtmh.24-0719. Print 2025 Jun 4.
India's National Malaria Elimination Program, which achieved notable success in reducing cases, is now facing challenges because of the rise in malaria cases in 2023 and 2024. This increase is linked to multiple factors, including disruptions in healthcare priorities during the coronavirus disease 2019 pandemic, drug and insecticide resistance, and the under-detection of asymptomatic carriers and pfhrp2-deleted parasites. The ultimate goal is to achieve sustainable reductions in malaria incidence and transmission, paving the way for a malaria-free India by 2030.
印度的国家消除疟疾计划在减少疟疾病例方面取得了显著成功,但由于2023年和2024年疟疾病例的增加,目前正面临挑战。这种增加与多种因素有关,包括2019冠状病毒病大流行期间医疗保健重点的中断、药物和杀虫剂耐药性,以及无症状携带者和pfhrp2缺失寄生虫的检测不足。最终目标是实现疟疾发病率和传播的可持续降低,为到2030年实现无疟疾的印度铺平道路。